Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT00831727
Other study ID # 23614
Secondary ID SSHRC 767-2007-2
Status Active, not recruiting
Phase N/A
First received January 28, 2009
Last updated April 14, 2010
Start date February 2009
Est. completion date February 2010

Study information

Verified date April 2010
Source University of Toronto
Contact n/a
Is FDA regulated No
Health authority Canada: Ethics Review Committee
Study type Interventional

Clinical Trial Summary

The purpose of the present study is twofold. First, we will attempt to examine the role that emotion regulation and self-presentation play as potential moderators in the expressive writing paradigm. We hypothesize that expressive writing participants who demonstrate greater abilities to regulate their emotions at baseline will improve more on our outcome measures. We also hypothesize that those expressive writing participants who demonstrate higher levels of self-presentation at baseline will improve less on our outcome measures.

The second aim of the study has two related objectives. First, we will attempt to investigate whether the expressive writing intervention can increase and enhance an individual's emotion regulation abilities. Related to this, we will then go on to examine whether emotion regulation can be looked at as a potential mechanism of action in the expressive writing procedure. Related to these two objectives, we hypothesize that in comparison to the control group, participants in the expressive writing condition will show increases in their ability to regulate their emotions from baseline to four week follow up. Moreover, we predict that greater gains in emotion regulation abilities for the expressive writing participants will be significantly related to greater gains in outcome measures.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 90
Est. completion date February 2010
Est. primary completion date December 2009
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- Fluent in English

- Previously experienced trauma (not current or ongoing; excluding bereavement)

- Currently experiencing trauma-related distress

Exclusion Criteria:

- Currently involved in psychotherapy

- Currently taking psychotropic medications

- Imminent threat to self or others

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment


Intervention

Behavioral:
Expressive Writing
Participants will write about their experienced trauma for 20 minutes on each of three consecutive days using techniques associated with expressive writing
Control
Participants will write as factually as possible about an assigned trivial topic for 20 minutes on each of three consecutive days

Locations

Country Name City State
Canada Ontario Institute for Studies in Education of the University of Toronto Toronto Ontario

Sponsors (1)

Lead Sponsor Collaborator
University of Toronto

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Posttraumatic Stress Diagnostic Scale Initial session; One month follow-up No
Secondary Difficulties in Emotion Regulation Scale Initial session; One month follow-up No
Secondary Pennebaker Inventory of Limbic Languidness Initial session; One month follow-up No
Secondary Beck Depression Inventory, Second Edition Initial session; One month follow-up Yes
See also
  Status Clinical Trial Phase
Terminated NCT00611871 - The Use of Propranolol to Block Memory Reconsolidation in PTSD Phase 2
Completed NCT02057081 - Multifamily Group to Reduce Marital Conflict and Disability in Veterans With mTBI N/A
Completed NCT03684473 - An Online CBT, Mindfulness Meditation & Yoga (CBT-MY) Intervention for Posttraumatic Stress Disorder N/A
Active, not recruiting NCT00965809 - Add on Study on Δ9-THC Treatment for Posttraumatic Stress Disorders (PTSD) Phase 4
Unknown status NCT01033708 - A Randomized Control Trial of Narrative Exposure Therapy Versus Treatment as Usual in the Therapy of Borderline Personality Disorder N/A
Completed NCT02774642 - Integrated CBT-I and PE on Sleep and PTSD Outcomes (Impact Study) N/A
Completed NCT01049516 - Prolonged Exposure for Post Traumatic Stress Disorder (PTSD) Among Operation Iraqi Freedom/Operation Enduring Freedom (OIF/OEF) Personnel N/A
Completed NCT00105885 - Telephone Care as a Substitute for Routine Psychiatric Medication N/A
Completed NCT02556645 - A Comparison of Web-Prolonged Exposure (Web-PE) and Present-Centered Therapy (PCT) for PTSD Among Active-Duty Military Personnel N/A
Recruiting NCT01743664 - The Efficacy of EMDR in Patients With PTSD in Multiple Sclerosis Phase 3
Completed NCT01158001 - Telemedicine for Improved Delivery of Psychosocial Treatments for Post Traumatic Stress Disorder N/A
Completed NCT03997344 - Veterans Nature Therapy (Vet Hike) N/A
Completed NCT01605253 - Eszopiclone for the Treatment of Posttraumatic Stress Disorder Phase 4
Not yet recruiting NCT02384369 - Trial of Oral SNC-102 in Subjects With Combat-Related Posttraumatic Stress Disorder Phase 2
Enrolling by invitation NCT02757339 - Evaluating the Neurobiological Basis of Traumatic Dissociation in Women With Histories of Abuse and Neglect
Active, not recruiting NCT01157416 - Effect of D-cycloserine on Treatment of Posttraumatic Stress Disorder (PTSD) in Youth Phase 2
Completed NCT01208844 - Study of Physical Health for Women With Posttraumatic Stress or Depression N/A
Not yet recruiting NCT01914861 - Cortisol Diurnal Variation and the Risk for Developing Post Traumatic Stress Disorder N/A
Unknown status NCT01644851 - Cognitive Training for Post Traumatic Stress Disorder: Effects on Cognitive, Emotional, and Brain Function N/A
Completed NCT01896388 - Ifenprodil Tartrate Treatment of Adolescents With Post-traumatic Stress Disorder: a Double-blind, Placebo-controlled Trial Phase 1/Phase 2